>>> US Gapping up

Gapping up
In reaction to earnings/guidance:
  • MYGN +31.8%, CYRX +26.6%, FLYW +19.5%, GO +19.3%, ALAB +18.2%, RNG +15.2% (also names new CFO; also renewed collaboration with NICE), SHOP +15.2%, ANGI +14.9%, FTRE +14.6%, CRCT +14.2%, ANET +13%, HNGE +12.1%, KVYO +11.6%, LRN +11.3%, QDEL +10.9%, SKY +10.5%, DNOW +10.2%, CPRI +10.2%, PRCH +10.1%, GERN +10%, ZETA +9.5%, CURI +9.3%, TBLA +9%, HALO +8.9%, LEU +8.7%, WIX +8.7%, QLYS +8.3%, ATEN +7.6%, REZI +7.5%, CRL +7.5%, ADPT +6.7%, SGC +6.6%, DT +6.5%, GILT +6.4%, RVLV +6%, MTCH +6%, NYT +5.9%, ARDT +5.5%, BCO +5.5%, SSRM +5.2%, PCTY +5.2% (also share buyback auth increased by $500 mln), TRMB +5.2%, EXTR +5%, WWW +4.9%, CBLL +4.8%, IOSP +4.7%, IGIC +4.6%, GPN +4.6%, VVV +4.6%, IFF +4.5% (also to divest soy crush, concentrates & lecithin business; also authorizes new $500 mln share repurchase program), SUPN +4.3%, DV +4.2%, SWKS +3.9% (also increases dividend), NCMI +3.7% (also files for $300 mln mixed securities shelf offering), TDC +3.4%, ENLT +3.4%, MCD +3.3%, ACHC +3.1%, CRUS +3%, ONC +3%, OC +3%, VSH +3%, GEO +2.9%, CDW +2.9%, CG +2.8%, NAMS +2.6%, JELD +2.4%, LMAT +2.2%, HMC +2%, ODP +2%, DEI +1.9%, RIGL +1.8%, DBD +1.7%, DAY +1.6%, AFG +1.5%, BWIN +1.5%, IRM +1.5%, SAFE +1.4%, OUT +1.1%, SPR +1.1%, ITUB +1.1%, INSW +1.1%, BL +1% (also Therese Tucker, Co-CEO and Founder, to transition from her role as Co-CEO; Owen Ryan, currently Co-CEO and Chairman, will continue as sole CEO), MIDD +1%, CHH +0.9%
Other news:
  • CIX +7% (declares special div of $1/sh)
  • MDXH +4.4% (MDXH to acquire Exosome Diagnostics from TECH)
  • IONQ +2.8% (AMZN discloses new position in IONQ)
  • SPWH +2.3% (names new CFO)
  • JANX +2% (announces dosing of first patient in its TRACTr collaboration with Merck)
  • ICFI +1.9% (launches ICF Fathom, a new suite of AI offerings for federal agencies)
Analyst comments:
  • DRVN +3% (upgraded to Overweight from Neutral at JPMorgan)
  • HOLX +2.5% (upgraded to Outperform from Sector Perform at RBC Capital)
  • MNDY +1.7% (upgraded to Outperform from Neutral at Robert Baird)
  • KMX +1.2% (upgraded to Neutral from Underweight at JPMorgan)
  • INCY +1.2% (upgraded to Overweight from Equal Weight at Wells Fargo)
  • AFYA +1% (upgraded to Overweight from Underweight at Morgan Stanley)
  • BRBR +0.8% (upgraded to Overweight from Equal Weight at Stephens)
  • VRTX +0.8% (upgraded to Overweight from Equal Weight at Wells Fargo)